Why Is Anterix (ATEX) Down 5.5% Since Last Earnings Report?

It has been about a month since the last earnings report for Anterix (ATEX). Shares have lost about 5.5% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Anterix due for a breakout? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Anterix Inc. before we dive into how investors and analysts have reacted as of late.

Anterix Reports Narrower-Than-Expected Q1 Loss on Solid Revenue Growth

Anterix reported mixed first-quarter fiscal 2027 results, wherein the top line missed the Zacks Consensus Estimate, but the bottom line beat the same.

The company delivered 38.1% year-over-year revenue growth, driven by higher spectrum revenues. It also advanced its broadband spectrum business through new license activity and customer partnerships, while spectrum-clearing costs continued to weigh on the bottom line.

Net Income

On a GAAP basis, net income was $0.24 million or 1 cent per share compared with $25.18 million or $1.35 per share in the prior-year quarter. Despite top-line growth, lower gain on the exchange of intangible assets impacted profitability during the quarter.

Excluding non-recurring items, Anterix reported a non-GAAP net loss of 53 cents per share compared with a net loss of 48 cents per share in the prior-year quarter. The bottom line was narrower than the Zacks Consensus Estimate loss of 55 cents.

Revenues & Other Details

Spectrum revenues rose to $1.96 million from $1.42 million. The figure missed the consensus estimate of $1.97 million. 

During the first quarter of fiscal 2027, the company’s operating expenses totaled $12.86 million compared with $13.81 million in the year-ago quarter. Operating loss in the quarter was $0.25 million against operating income of $22.48 million in the year-ago quarter.

Cash Flow & Liquidity

As of June 30, 2026, Anterix had total cash and cash equivalents and restricted cash of $119.92 million compared with $48.58 million a year ago, with no outstanding debt. The company generated $2.05 million in cash from operations during the reported quarter compared to cash utilization of $3.14 million in the prior-year quarter. No share repurchases occurred during the quarter, with $226.7 million remaining under buyback authorization. 

In fiscal 2027, management expects to receive approximately $9.6 million of contracted customer cash proceeds.

How Have Estimates Been Moving Since Then?

In the past month, investors have witnessed a upward trend in estimates review.

VGM Scores

At this time, Anterix has a poor Growth Score of F, however its Momentum Score is doing a lot better with an A. However, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy.

Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.

Outlook

Estimates have been trending upward for the stock, and the magnitude of this revision looks promising. Notably, Anterix has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research